Back
Entergy Corp. 10K Form
Buy
55
ETR
Entergy Corp.
Last Price:
$94.44
Seasonality Move:
0.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | ETR/Entergy Corp. Quarterly |
| 2023-11-02 | 10Q | ETR/Entergy Corp. Quarterly |
| 2023-08-03 | 10Q | ETR/Entergy Corp. Quarterly |
| 2023-05-04 | 10Q | ETR/Entergy Corp. Quarterly |
| 2022-11-03 | 10Q | ETR/Entergy Corp. Quarterly |
| 2022-08-04 | 10Q | ETR/Entergy Corp. Quarterly |
Receive ETR News And Ratings
See the #1 stock for the next 7 days that we like better than ETR
ETR Financial Statistics
Sales & Book Value
| Annual Sales: | $11.9B |
|---|---|
| Cash Flow: | $207.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $37.31 |
| Price / Book: | 2.53 |
Profitability
| EPS (TTM): | 4.05230 |
|---|---|
| Net Income (TTM): | $1.8B |
| Gross Margin: | $3.3B |
| Return on Equity: | 11.41% |
| Return on Assets: | 2.72% |
Entergy Corp. Earnings Forecast
Key Entergy Corp. Financial Ratios
-
The Gross Profit Margin over the past 45 years for ETR is 28.19%.
-
The Selling, General & Administrative Expenses for ETR have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 108.45% of Operating Income.
-
The Net Earning history of ETR is 8.93% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 24 years.
Entergy Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Electric Utilities |
| Sector: | Utilities |
| Current Symbol: | ETR |
| CUSIP: | 29364G |
| Website: | entergy.com |
Debt
| Debt-to-Equity Ratio: | 1.8 |
|---|---|
| Current Ratio: | 0.7 |
| Quick Ratio: | 0.39 |
Price-to-Earnings
| Trailing P/E Ratio: | 38.62 |
|---|---|
| Forward P/E Ratio: | 21.5 |
ETR Technical Analysis vs Fundamental Analysis
Buy
55
Entergy Corp. (ETR)
is a Buy
Is Entergy Corp. a Buy or a Sell?
-
Entergy Corp. stock is rated a BuyThe current Entergy Corp. [ETR] share price is $94.46. The Score for ETR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.